CLARIDGES LONDON

Brand Owner (click to sort) Address Description
CLARIDGE'S OF LONDON The Savoy Hotel Limited 1 Savoy Hill London WC2R 0BP United Kingdom CLARIDGES OF LONDON;LONDON;Hotel services, making hotel reservations for others, restaurant services, catering services, canteen services, cafe services, cafeteria services, and snack bar services;
CLARIDGE'S OF LONDON Claridge's Hotel Limited 41-43 Brook Street Mayfair, London W1K4HJ United Kingdom CLARIDGES OF LONDON;Apparatus and installations for lighting; lamps; lampshades; lightshades; light fittings; fixtures and fittings for lighting; light bulbs; lanterns; parts and fittings for the aforesaid goods; furniture; mirrors; picture frames; Paints; varnishes; lacquers; stainers; preservatives; colouring preparations; wood fillers; preparations for providing a finish to wood surfaces; wood stains; mastics; rubber coatings; oils for the treatment of wood; oils for the preservation of wood; hand tools; cutlery; knives; forks; spoons; -metallic building materials; tiles; floor tiles; wall tiles; textiles and textile goods; bed covers; table covers; sheets; tablecloths; napkins; towels; tea towels; bath mats and covers; cushion covers; pillowcases; duvet covers; wall paper; wall coverings; borders; friezes; floor coverings; carpets; rugs; mats; carpet tiles; linoleum; domestic utensils and containers, tableware, glassware, articles of porcelain, earthenware, glass, vases, candle holders;LONDON;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. The construction of transgenic animal models of human Alzheimer's disease, and methods of using the models to screen potential Alzhe## disease therapeutics, are described. The models are characterized by pathologies similar to pathologies observed in Alzheimer's disease, based on expression of all three forms of the ?-amyloid precursor protein (APP), APP695, APP751, and APP770, as well as various point mutations based on naturally occurring mutations, such as the London and Indiana familial Alzheimer's disease (FAD) mutations at amino acid 717, predicted mutations in the APP gene, and truncated forms of APP that contain the A? region. Animal cells can be isolated from the transgenic animals or prepared using the same constructs with standard techniques such as lipofection or electroporation. The transgenic animals, or animal cells, are used to screen for compounds altering the pathological course of Alzheimer's disease as measured by their effect on the amount of APP, ?-amyloid peptide, and numerous other Alzheimer's disease markers in the animals, the neuropathology of the animals, as well as by behavioral alterations in the animals.